BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

betahistine dihydrochloride, Quantity: 8 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

betahistine dihydrochloride

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Mode d'administration:

Oral

Unités en paquet:

100 tablets, 10 tablets, 25 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Descriptif du produit:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-11-10